Published on January 2021 | Drug analysis, COVID-19

Pharmacological Insight into Possible Treatment Agents for the Lethal Covid-19 Pandemic in Kurdistan Region- Iraq

The magnitude of the risks in the face of the COVID-19 disease is increasing every day, and foreshadowing a catastrophe facing humanity. It is clear, the levels of health services in different countries around the world are very different, therefore there will be many health risks in countries that are suffering in terms of health services. The objective of this study was to compare different therapy for patients with severe coronaviruses diseases (COVID-19). Nowadays, different medicines have been used to reduce the severity of symptoms of this disease such as Ribavirin, Chloroquine, Arbidol, Lopinavir/Ritonavir, Favipiravir, Remdesivir, Azithromycin, and Sputnik V. These medications are used in every region of the world to make some progress in finding a solution to (COVID-19), including Kurdistan region which is in the north of Iraq. As is the case in most third world countries, the health service is not at the required level, and despite that, we were able to make a comprehensive list of medicines used in many countries of the world and here in Kurdistan, Iraq. In addition to this narrative and comparison of the best medication used to treat this pandemic, we also surveyed the opinions of over 100 people on the medicines discussed in this study throughout their treatment. The medicinal properties of medications used for COVID-19 and the results of their use on humans were studied in this review to promote appropriate medications for the treatment of coronavirus.